
Advertise on podcast: Talking Points
Rating
4from
This podcast has
214 episodes
Language
EnglishPublisher
TCTMDExplicit
No
Date created
2016/03/16
Latest episode
2026/11/04
Average duration
13 min.
Release period
22 days
Description
A selection of the best interviews conducted by physician leaders and recorded at cardiology conferences around the globe. 06f763f0-76e5-11f0-bb7c-8557ae1d8a8b
Unlock Talking Points podcast Email contact info,
Listeners & Audience details
Email contact information
Direct podcast contact details

Listeners
Audience numbers & engagement insights

Audience details
Podcast Insights

Podcast episodes
Check latest episodes from Talking Points podcast
The Evolut Low Risk Trial
2026/11/04
Michael J. Reardon and C. Michael Gibson discuss the 5-year outcomes of TAVR or SAVR in low-risk patients with AS.
The BHF PROTECT-TAVI Trial
2026/10/14
Can routine cerebral embolic protection reduce stroke risk in TAVI? Rajesh Kharbanda and C. Michael Gibson discuss.
The FAME 3 Trial
2026/09/16
William Fearon and C. Michael Gibson break down the final 5-year follow-up of the study comparing FFR-guided PCI vs CABG for patients with three-vessel CAD.
The TRILUMINATE Pivotal Trial
2026/09/02
Saibal Kar and C. Michael Gibson look at the 2-year outcomes of transcatheter edge-to-edge repair for tricuspid regurgitation.
The PRAGUE-25 Study
2026/08/05
Pavel Osmancik and C. Michael Gibson discuss whether catheter ablation is superior to risk factor modification with antiarrythmic drugs for the treatment of AF.
The BETAMI-DANBLOCK Trial
2026/07/22
How does discontinuing beta-blockers after MI affect outcomes in patients without HF? Dan Atar and C. Michael Gibson break it down.
New York Valves 2026: Implications of the Proposed National Coverage Determination for TAVI
2026/07/01
In one of the most thought-provoking sessions at New York Valves 2026, Michael Mack and Roxana Mehran moderate a panel discussion looking at the future of TAVI from all angles.
The PROCTOR Trial
2026/06/03
Ruben de Winter and C. Michael Gibson compare clinical outcomes of native vessel versus SVG PCI for patients with prior CABG.
The SELUTION DeNovo Trial
2026/05/20
Christian M. Spaulding and C. Michael Gibson look at the 1-year results from the study comparing sirolimus-eluting DCB with DES for de novo coronary lesions.
The VESALIUS-CV Trial
2026/05/06
Paul Burton and C. Michael Gibson discuss the effects of adding evolocumab for patients at high risk for CV events but without prior MI or stroke.
The META-AF Trial
2026/04/22
Amrish Deshmukh talks to C. Michael Gibson about the use of metformin as an adjunctive therapy to catheter ablation of AF.
Evolution of Pharmacotherapy in STEMI
2026/04/01
How has the pharmacotherapy for STEMI changed over the past 46 years? Ginger Jiang and C. Michael Gibson discuss treating patients with zalunfiban at first medical contact.
The CorCMR Trial
2026/03/04
Colin Berry and C. Michael Gibson discuss whether stress CMR imaging is helpful in patients with angina and no obstructive CAD.
The TUXEDO-2 Trial
2026/02/04
Sripal Bangalore and C. Michael Gibson discuss whether ticagrelor is noninferior to prasugrel in patients with diabetes and multivessel CAD undergoing PCI.
The FLOW Trial
2026/01/07
C. Michael Gibson talks to Katherine Tuttle about semaglutide's positive effects in patients with diabetes and chronic kidney disease.
Podcast sponsorship advertising
Start advertising on Talking Points relevant audience podcasts
You may also like to advertise on these Podcasts

4.7132874
10 to Life
Annie Elise

4.76762467
Criminology
Emash Digital & Mike Ferguson, Mike Morford

4.87552988
The Dr. John Delony Show
Ramsey Network

4.512663675
RedHanded
RedHanded

4.7278962000
The Matt Walsh Show
The Daily Wire

4.959962000
Legal AF by MeidasTouch
MeidasTouch Network

4.7292842000
The Michael Knowles Show
The Daily Wire

4.897081456
The Graham Allen Show
Graham Allen

4.930902000
The Quote of the Day Show | Daily Motivational Talks
Sean Croxton

4.7106622000
FantasyPros - Fantasy Football Podcast
iHeartPodcasts